Bildnachweis: VentureCapital Magazin, Pixabay.
Like a sword of Damocles, a concern hangs over every life sciences start-up founded in Germany: will the company remain headquartered in Germany – and with it the underlying technology – or is there a risk of relocation abroad? This issue is not only on the minds of founders and investors; it is also repeatedly debated by policymakers, both in Germany and at EU level.
At the end of 2025, the European Commission presented the EU Biotech Act, a legislative proposal designed, as part of a broader industrial policy strategy, to strengthen Europe’s position in the global biotech race. The core idea is to establish Europe as a leading location for biotechnology and biomanufacturing. With increased capital, improved regulation, and a stronger focus on support mechanisms, the primary aim is to bolster the healthcare sector. We have therefore put the EU Biotech Act through a reality check and asked life sciences experts what the industry can expect at both EU and national level through to 2027.
Read the first Impact Life Sciences 2026 now!
In our cover interview, we spoke with Robin Lauber. The Swiss entrepreneur is co-founder of the family office Infinitas Capital. Coming from a real estate entrepreneurial family, he focuses on longevity, impact, and next-generation investing. He offers insights into the Swiss life sciences sector and discusses his motivation and investment track record to date.
This year’s first Impact Life Sciences issue also examines the early stages of company formation and financing. We present current funding opportunities, offer guidance on securing public funding, and feature case studies of early-stage start-ups on their journey to market.
In addition, we are launching a new series in 2026: ‘Radiotheranostics: the next wave of precision oncology.’ This four-part series aims to explore the innovation potential, major players, financing dynamics, and ecosystem enablers of radiotheranostics in the DACH region. Part one focuses on the German radiotherapy market and selected companies.
Find the full issue in our e-shop here!
